Summary The German Merck KGaA combines a unique portfolio of pharmaceuticals and specialty chemicals for the electronic industry. Merck Serono is a leading player in the biopharmaceutical industry, but with a slim pipeline. The Performance ... Seeking Alpha, 3 days ago
TOKYO—Daiichi Sankyo and , a specialty pharmaceutical company specializing in the research and development of novel pain products that prevent or significantly reduce nausea and vomiting, have announced a strategic collaboration. Through this ...Drug Discovery News, 2 weeks ago Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, … Yahoo! Finance, 2 weeks ago
on Thursday said that its plant at Puducherry has commenced its additional line of production of suppositories - a unique feature which only a few pharmaceutical companies have. This will enable the company to export these products to semi- and non-regulated ...Business Line, 1 month ago
Sosei and SNBL have executed a Letter of Intent to negotiate the terms for co- development of pharmaceutical products Sosei has decided to finance the initial period expenses for the SNBL and G2B Pharma co-development project of a ...Noodls, 1 week ago
New Zealand's only full service geothermal and groundwater laboratory, unique in the Southern Hemisphere, opened for business this week after a $4 million upgrade. The 1100 square metre facility, at GNS Science's Wairakei campus north of Taupo, ...Yahoo!Xtra, 2 weeks ago
PR Newswire HORSHOLM, Denmark, Aug. 20, 2014 HORSHOLM, Denmark , Aug. 20, 2014 /PRNewswire/ -- Highlights: On 28 July the European Commission granted marketing authorization for Envarsus® for the prevention of organ rejection in ...Reuters, 2 days ago Veloxis Pharmaceuticals A/S Announces Financial Results For The First Six Months Of 2014 BioSpace, 1 day ago
Skinvisible Pharmaceuticals, Inc. announced the forming of Kintari, a new wholly-owned subsidiary to market a premium line of scientifically...
SpecialChem - Aug 18, 2014 LAS VEGAS, NV-- Skinvisible Pharmaceuticals, Inc. announced the forming of Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skincare products powered by the ...SpecialChem, 4 days ago
Avion Pharmaceuticals, LLC, announces the signing of a commercial license agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) for the development and commercialization of four Captisol-enabled programs. Under the terms of the ...Citybizlist, 3 days ago Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products BusinessWeek, 1 week ago LIGAND PHARMACEUTICALS : Avion Pharmaceuticals, LLC :, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products 4 Traders, 1 week ago
International Conference and Exhibition on Pharmacovigilance (and) Clinical Trials to be Held in Hyderdbad
OMICS Group International is all set to organize 3 rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials in Hyderabad. It will be held from October 27-29 this year at Hyderabad International Convention Centre, ...MedIndia, 6 days ago
New treatments for patients challenge manufacturers to ramp up production; solutions can be found at Pharma EXPO 2014 Biopharmaceuticals are at the forefront of medical research, and there is no doubt that demand is increasing for bio-based ...Pharmaceutical Online, 6 days ago
on your WebpageAdd Widget >Get your members hooked!